Compound
CJC-1295 No DAC
Research Profile
CJC-1295 No DAC
Educational laboratory reference
Peptide Vault Labs Education
Also known as Modified GRF 1-29, Mod GRF 1-29
Primary research target
GHRH-receptor agonist research focused on pulsatile growth-hormone signaling and endocrine pharmacology.
Research category
GHRH analogs, ghrelin-receptor agonists, secretagogues, and related endocrine research materials.
Educational research information only
This profile describes areas of scientific interest. It does not provide medical advice, dosing, reconstitution, administration, treatment, or human-use instructions.
Compound
CJC-1295 No DAC
Research category
Growth Hormone Signaling
Information type
Educational overview
Related research

Selective ghrelin-receptor agonist investigated in growth-hormone secretion and endocrine signaling research.

Stabilized GHRH analog with established clinical and regulatory literature involving growth-hormone-axis pharmacology.

Potent ghrelin-receptor agonist investigated in growth-hormone secretion and cardiovascular and endocrine models.

Modified IGF-1 analog investigated in receptor signaling, cell growth, protein synthesis, and prolonged IGF-binding-protein resistance.
The Peptide Vault Labs Research Library is provided solely for educational, analytical, and laboratory research reference. Content does not diagnose, treat, cure, or prevent disease and must not be interpreted as prescribing, dosing, administration, reconstitution-for-use, or patient-care guidance. Experimental findings—especially animal, cell, and in vitro findings—do not establish safety or efficacy in humans. Researchers must use validated institutional protocols, applicable laws, safety data sheets, certificates of analysis, and qualified laboratory oversight.